Cerner Announces Next Evolution of Cerner Millennium®

CernerCerner (Nasdaq: CERN) announced the launch of Millennium+™, the next evolution of Cerner Millennium®. Combining the enterprise platform with the secure Cerner Cloud, Millennium+ delivers a new user experience that is fast, smart and easy. It provides personalized, intuitive and relevant clinical workflows via the desktop, tablet and smartphone.

Cerner understands the importance of health system and community interoperability, which is why Millennium+ integrates and unifies information gathered within the organization and across the community into a provider's workflow. Millennium+ is designed to speed up workflows, reduce clicks and ensure Cerner solutions provide each user the information they need at the right point in the workflow in context of the person, condition and venue.

In addition to Sepsis alerting and Chart Search, one of the first solutions that will be launched as part of the Millennium+ platform is PowerChart+Touch™. PowerChart+Touch was created specifically for the iPad. With a swipe of a finger, providers can quickly and easily navigate workflows. As part of the Millennium+ platform, solutions are available on-demand versus relying on major release schedules to access to new capabilities. This provides client organizations, departments and individual users to more quickly adapt to new capabilities, regulatory mandates and quality measurements.

"Cerner is going beyond foundational automation of the health record and creating a new experience; not just a repository to chart activity or place orders," said Jeff Townsend, Cerner chief of staff and executive VP. "With this new combination of capabilities, Cerner is well positioned to accelerate innovation around the second order effects of a digitized industry. What you can do now with Millennium+ is much more than just being paperless, it moves the boundaries beyond a typical Enterprise Health Record system."

Millennium+ creates a new user experience that is:

Fast

  • Millennium+ is designed for optimal performance. The solution speeds up access to comprehensive clinical workflows, anticipating the data requirements to complete end-to-end experiences while reducing clicks and improving context of care.

Smart

  • Millennium+ is smart and aware of the context of the patient, the location and the user. It anticipates "next," and brings information face up in the context of the next decision or action, making it moment relevant.

Easy

  • Millennium+ is easy to use. The interaction is intuitive, with minimal training and configuration required.

Millennium+ solutions are currently rolling out to physicians through the end of the year and to additional providers through 2013.

About Cerner
Cerner is contributing to the systemic change of health and care delivery. For more than 30 years Cerner has been executing its vision to make health care safer and more efficient. We started with the foundation of digitizing paper processes and now offer the most comprehensive array of information software, professional services, medical device integration, remote hosting and employer health and wellness services. Cerner systems are used by everyone from individual consumers, to single-doctor practices, hospitals, employers and entire countries. Taking what we’ve learned over more than three decades, Cerner is building on the knowledge that is in the system to support evidence-based clinical decisions, prevent medical errors and empower patients in their care.

Cerner® solutions are licensed by approximately 9,300 facilities around the world, including more than 2,650 hospitals; 3,750 physician practices; 40,000 physicians; 500 ambulatory facilities, such as laboratories, ambulatory centers, cardiac facilities, radiology clinics and surgery centers; 800 home health facilities; 40 employer sites and 1,600 retail pharmacies.

Certain trademarks, service marks and logos (collectively, the "Marks") set forth herein are owned by Cerner Corporation and/or its subsidiaries in the United States and certain other countries throughout the world. All other non-Cerner Marks are the property of their respective owners. Nasdaq: CERN.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...

AI-Based Chatbot Created for Bioimage An…

Scientists from Universidad Carlos III de Madrid (UC3M), together with a research team from Ericsson and the KTH Royal Institute of Technology in Sweden, have developed an artificial intelligence-based software...